France has eased rules over how doses are delivered to its people in a country where anti-vaccine sentiments are prominent. The EU has lagged behind countries such as the US and UK in its delivery programme. The drug regulator in Brussels took longer to approve a first vaccine for the Pfizer/BioNTech vaccine quickly. For instance, the Netherland only vaccinated its first person on Wednesday despite the drug arriving in the country on December 27. The European Commission, which has signed deals with six vaccine manufacturers for two billion doses, has been blamed by some for the delay. Some claim it did not buy enough doses of the Pfizer/BioNTech vaccine, the first to be approved by Brussels’ regulators – although the EU’s executive branch denied this.